Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis

Balazs Hegedus, Tu Hsueh Yeh, Da Yong Lee, Ryan J. Emnett, Jia Je Li, David H. Gutmann

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain development, we recently generated mice in which Nf1 gene inactivation occurs in neuroglial progenitor cells using the brain lipid binding protein (BLBP) promoter. We found that Nf1BLBPCKO mice exhibit significantly reduced body weights and anterior pituitary gland sizes. We further demonstrate that the small anterior pituitary size reflects loss of neurofibromin expression in the hypothalamus, leading to reduced growth hormone releasing hormone, pituitary growth hormone (GH) and liver insulin-like growth factor-1 (IGF1) production. Since neurofibromin both negatively regulates Ras activity and positively modulates cAMP levels, we examined the signaling pathway responsible for these abnormalities. While BLBP-mediated expression of an activated Ras molecule did not recapitulate the body weight and hypothalamic/pituitary defects, treatment of Nf1BLBPCKO mice with rolipram to increase cAMP levels resulted in a partial restoration of the body weight phenotype. Furthermore, conditional expression of the Ras regulatory GAP domain of neurofibromin also did not rescue the body weight or Igf1 mRNA defects in Nf1BLBPCKO mice. Collectively, these data demonstrate a critical role for neurofibromin in hypothalamic-pituitary axis function and provide further insights into the short stature and GH deficits seen in children with NF1.

Original languageEnglish
Pages (from-to)2956-2966
Number of pages11
JournalHuman Molecular Genetics
Volume17
Issue number19
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Neurofibromin 1
Neurofibromatosis 1 Genes
Body Weight
Growth
Growth Hormone
ras GTPase-Activating Proteins
Rolipram
Growth Hormone-Releasing Hormone
Neurofibromatosis 1
Anterior Pituitary Gland
Gene Silencing
Somatomedins
Neuroglia
Hypothalamus
Stem Cells
Phenotype
Messenger RNA
Liver
Brain

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Hegedus, B., Yeh, T. H., Lee, D. Y., Emnett, R. J., Li, J. J., & Gutmann, D. H. (2008). Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Human Molecular Genetics, 17(19), 2956-2966. https://doi.org/10.1093/hmg/ddn194

Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. / Hegedus, Balazs; Yeh, Tu Hsueh; Lee, Da Yong; Emnett, Ryan J.; Li, Jia Je; Gutmann, David H.

In: Human Molecular Genetics, Vol. 17, No. 19, 2008, p. 2956-2966.

Research output: Contribution to journalArticle

Hegedus, B, Yeh, TH, Lee, DY, Emnett, RJ, Li, JJ & Gutmann, DH 2008, 'Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis', Human Molecular Genetics, vol. 17, no. 19, pp. 2956-2966. https://doi.org/10.1093/hmg/ddn194
Hegedus, Balazs ; Yeh, Tu Hsueh ; Lee, Da Yong ; Emnett, Ryan J. ; Li, Jia Je ; Gutmann, David H. / Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. In: Human Molecular Genetics. 2008 ; Vol. 17, No. 19. pp. 2956-2966.
@article{b4477ca058f84d9aac23a8046e9502e1,
title = "Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis",
abstract = "To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain development, we recently generated mice in which Nf1 gene inactivation occurs in neuroglial progenitor cells using the brain lipid binding protein (BLBP) promoter. We found that Nf1BLBPCKO mice exhibit significantly reduced body weights and anterior pituitary gland sizes. We further demonstrate that the small anterior pituitary size reflects loss of neurofibromin expression in the hypothalamus, leading to reduced growth hormone releasing hormone, pituitary growth hormone (GH) and liver insulin-like growth factor-1 (IGF1) production. Since neurofibromin both negatively regulates Ras activity and positively modulates cAMP levels, we examined the signaling pathway responsible for these abnormalities. While BLBP-mediated expression of an activated Ras molecule did not recapitulate the body weight and hypothalamic/pituitary defects, treatment of Nf1BLBPCKO mice with rolipram to increase cAMP levels resulted in a partial restoration of the body weight phenotype. Furthermore, conditional expression of the Ras regulatory GAP domain of neurofibromin also did not rescue the body weight or Igf1 mRNA defects in Nf1BLBPCKO mice. Collectively, these data demonstrate a critical role for neurofibromin in hypothalamic-pituitary axis function and provide further insights into the short stature and GH deficits seen in children with NF1.",
author = "Balazs Hegedus and Yeh, {Tu Hsueh} and Lee, {Da Yong} and Emnett, {Ryan J.} and Li, {Jia Je} and Gutmann, {David H.}",
year = "2008",
doi = "10.1093/hmg/ddn194",
language = "English",
volume = "17",
pages = "2956--2966",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis

AU - Hegedus, Balazs

AU - Yeh, Tu Hsueh

AU - Lee, Da Yong

AU - Emnett, Ryan J.

AU - Li, Jia Je

AU - Gutmann, David H.

PY - 2008

Y1 - 2008

N2 - To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain development, we recently generated mice in which Nf1 gene inactivation occurs in neuroglial progenitor cells using the brain lipid binding protein (BLBP) promoter. We found that Nf1BLBPCKO mice exhibit significantly reduced body weights and anterior pituitary gland sizes. We further demonstrate that the small anterior pituitary size reflects loss of neurofibromin expression in the hypothalamus, leading to reduced growth hormone releasing hormone, pituitary growth hormone (GH) and liver insulin-like growth factor-1 (IGF1) production. Since neurofibromin both negatively regulates Ras activity and positively modulates cAMP levels, we examined the signaling pathway responsible for these abnormalities. While BLBP-mediated expression of an activated Ras molecule did not recapitulate the body weight and hypothalamic/pituitary defects, treatment of Nf1BLBPCKO mice with rolipram to increase cAMP levels resulted in a partial restoration of the body weight phenotype. Furthermore, conditional expression of the Ras regulatory GAP domain of neurofibromin also did not rescue the body weight or Igf1 mRNA defects in Nf1BLBPCKO mice. Collectively, these data demonstrate a critical role for neurofibromin in hypothalamic-pituitary axis function and provide further insights into the short stature and GH deficits seen in children with NF1.

AB - To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain development, we recently generated mice in which Nf1 gene inactivation occurs in neuroglial progenitor cells using the brain lipid binding protein (BLBP) promoter. We found that Nf1BLBPCKO mice exhibit significantly reduced body weights and anterior pituitary gland sizes. We further demonstrate that the small anterior pituitary size reflects loss of neurofibromin expression in the hypothalamus, leading to reduced growth hormone releasing hormone, pituitary growth hormone (GH) and liver insulin-like growth factor-1 (IGF1) production. Since neurofibromin both negatively regulates Ras activity and positively modulates cAMP levels, we examined the signaling pathway responsible for these abnormalities. While BLBP-mediated expression of an activated Ras molecule did not recapitulate the body weight and hypothalamic/pituitary defects, treatment of Nf1BLBPCKO mice with rolipram to increase cAMP levels resulted in a partial restoration of the body weight phenotype. Furthermore, conditional expression of the Ras regulatory GAP domain of neurofibromin also did not rescue the body weight or Igf1 mRNA defects in Nf1BLBPCKO mice. Collectively, these data demonstrate a critical role for neurofibromin in hypothalamic-pituitary axis function and provide further insights into the short stature and GH deficits seen in children with NF1.

UR - http://www.scopus.com/inward/record.url?scp=52949132302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949132302&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddn194

DO - 10.1093/hmg/ddn194

M3 - Article

C2 - 18614544

AN - SCOPUS:52949132302

VL - 17

SP - 2956

EP - 2966

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 19

ER -